The Covid 19 pandemic has ravaged the Airline industry, dramatically reducing ticket and new aircraft sales. To compound the pain, the number of litigation claims against them for Aerotoxic Syndrome has increased even further, and to add to its woes the Specialist Class Action legal firms on both sides of the Atlantic are circling. These are the same teams that took on ‘Big Tobacco’ in the 90’s resulting in the Tobacco Master Settlement Agreement
Following a collective case management hearing before Judge Barbara Fontaine, regarding ‘Aerotoxicity Claims’ in 2018, it was agreed to transfer a ‘significant’ number of litigated industrial disease cases to the Royal Courts of Justice (RCJ) in London, ‘achieving greater certainty of outcome and an overall reduction in costs’. It also allows the RCJ to manage cases that have not yet been issued or served (‘intimated’ and ‘future’ claims).
See https://www.classactionlawsuithelp.com/aerotoxic-syndrome-class-action-lawsuit/ – https://www.bc-legal.co.uk/bcdn/925-279-sealed-collective-case-management-order-for-aerotoxic-syndrome-group-litigation.html
This decision has seen a proliferation of individual claims brought by employees or ex-employees of Airlines globally, and the now ‘Open Door Policy’ for claims via the Class Action Specialists.
The result for VN Aerotoxic Detection Solutions is an increasing market opportunity, with the need for ‘real-time’ onboard portable detection of TCP (tricresyl phosphate), and TBP (tributyl phosphate) becoming a necessity for aircraft operators and manufacturers in the face of legislation, which will inevitably follow the successful prosecution of employee claims.
To maximise the opportunity the Directors will seek VC funding both in Europe and the US to accelerate sensor testing, certification, design, manufacturing and distribution.